Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT ID: NCT04621201
Last Updated: 2023-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
120 participants
OBSERVATIONAL
2018-12-06
2026-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
NCT06076070
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
NCT01567046
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
NCT01585376
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438
Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma
NCT01342783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation and biopsy
biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with confirmed relapsed/refractory Osteosarcoma, Ewing Sarcoma or Synovial Sarcoma
3. Written informed consent signed by the patient, or parents or legal representative to perform molecular analysis of the tumor sample.
4. Patients aged ≤24 years
5. Pathological review of tumor samples.
6. Availability of fresh tumor sample from newly diagnosed or relapsed/refractory cancer and 10 ml of EDTA peripheral blood sample. Centralization of paraffin-embedded tumor sample might be optional.
Exclusion Criteria
24 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Associazione Italiana Ematologia Oncologia Pediatrica
OTHER
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Franca Fagioli
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franca Fagioli, MD
Role: PRINCIPAL_INVESTIGATOR
A.O.U. Città della Salute e della Scienza
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOU Città della Salute e della Scienza di Torino - Presidio Infantile Regina Margherita
Torino, Turin, Italy
Istituto Ortopedico Rizzoli
Bologna, , Italy
Policlinico S.Orsola-Malpighi
Bologna, , Italy
Azienda ospedaliero-universitaria Meyer
Florence, , Italy
Istituto Giannina Gaslini
Genova, , Italy
Istituto Nazionale Tumori
Milan, , Italy
Presidio Ospedaliero Gaetano Pini | ASST Pini-CTO
Milan, , Italy
Fondazione I.R.C.C.S. Policlinico San Matteo
Pavia, , Italy
Istituti fisioterapici Ospitalieri - Istituto Tumori Regina Elena e Istituto Dermatologico San Gallicano
Roma, , Italy
IRCCS materno infantile Burlo Garofolo
Trieste, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Emanuela Palmerini
Role: primary
Arcangelo Prete
Role: primary
Angela Tamburrini
Role: primary
Alberto Garaventa
Role: primary
Roberto Luksch
Role: primary
Marco Zecca
Role: primary
Marco Rabusin
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAR-GEN_ITA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.